Imaging of aluminium and amyloid β in neurodegenerative disease

Imaging of aluminium and amyloid β in neurodegenerative disease

Objectives: Recent research has confirmed the presence of aluminium in human brain tissue. Quantitative analyses suggest increased brain aluminium content in a number of neurodegenerative diseases including familial Alzheimer's disease, congophilic amyloid angiopathy, epilepsy and autism. Compl...

Full description

Bibliographic Details
Main Authors:	Christopher Exley, Matthew J. Mold
Format:	Article
Language:	English
Published:	Elsevier 2020-04-01
Series:	Heliyon
Subjects:	Neuroscience Health sciences Aluminium in brain tissue Alzheimer's disease Congophilic amyloid angiopathy Autism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844020306848

Similar Items

Multiple infarcts and hemorrhages in the central nervous system of a dog with cerebral amyloid angiopathy: a case report
by: Laís Limeira Rodrigues, et al.
Published: (2018-11-01)

Intracellular Aluminium in Inflammatory and Glial Cells in Cerebral Amyloid Angiopathy: A Case Report
by: Matthew Mold, et al.
Published: (2019-04-01)

Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives
by: Masashi Tanaka, et al.
Published: (2019-04-01)

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders
by: Yazan S. Batarseh, et al.
Published: (2016-03-01)

The cerebrovascular basement membrane: role in the clearance of β-amyloid and cerebral amyloid angiopathy
by: Alan W. J. Morris, et al.
Published: (2014-09-01)

Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Satoshi Saito, et al.
Published: (2017-04-01)

Histological and immunohistochemical characteristics of cerebral amyloid angiopathy in elderly dogs
by: Slađan Nešić, et al.
Published: (2017-01-01)

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets
by: Xue-mei Qi, et al.
Published: (2017-08-01)

Aluminium in Brain Tissue in Epilepsy: A Case Report from Camelford
by: Matthew Mold, et al.
Published: (2019-06-01)

Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo
by: Raya Al-Shawi, et al.
Published: (2016-01-01)

Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy
by: Saito, Satoshi
Published: (2017)

New Insights Into Blood-Brain Barrier Maintenance: The Homeostatic Role of β-Amyloid Precursor Protein in Cerebral Vasculature
by: Emma Ristori, et al.
Published: (2020-08-01)

In Vitro Studies of Flemish, Dutch, and Wild-Type β-Amyloid Provide Evidence for Two-Staged Neurotoxicity
by: Samir Kumar-Singh, et al.
Published: (2002-11-01)

A Simulation Model of Periarterial Clearance of Amyloid-beta from the Brain
by: Alexandra Katharina Diem, et al.
Published: (2016-02-01)

Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet–Mediated Amyloid Aggregation in Alzheimer’s Disease
by: Lili Donner, et al.
Published: (2021-09-01)

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
by: Anna M. De Kort, et al.
Published: (2021-09-01)

Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier – phenotypic variability in autosomal dominant Alzheimer’s disease
by: Grace M. Lloyd, et al.
Published: (2020-03-01)

New therapeutic approaches for Alzheimer’s disease and cerebral amyloid angiopathy
by: Satoshi eSaito, et al.
Published: (2014-10-01)

Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
by: Jörg Flemmig, et al.
Published: (2018-01-01)

In vivo detection of tau fibrils and amyloid β aggregates with luminescent conjugated oligothiophenes and multiphoton microscopy
by: Maria Calvo-Rodriguez, et al.
Published: (2019-11-01)

Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study
by: Ignazio Cali, et al.
Published: (2018-01-01)

Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease
by: David C. Hondius, et al.
Published: (2018-06-01)

Neutral sphingomyelinase activation in endothelial and glial cell death induced by amyloid beta-peptide
by: Ding-I Yang, et al.
Published: (2004-10-01)

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
by: Anuradha Tarafdar, et al.
Published: (2018-11-01)

Aluminium in Brain Tissue in Multiple Sclerosis
by: Matthew Mold, et al.
Published: (2018-08-01)

Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics
by: Jurre den Haan, et al.
Published: (2018-08-01)

Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy
by: Han Byung, et al.
Published: (2011-12-01)

Platelet and Plasma Phosphatidylcholines as Biomarkers to Diagnose Cerebral Amyloid Angiopathy
by: Bettina M. Foidl, et al.
Published: (2020-06-01)

Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy
by: Lisa S. Robison, et al.
Published: (2019-07-01)

10-Year Follow-Up of a Patient with Cerebral Amyloid Angiopathy
by: Min Kyoung Kang, et al.
Published: (2020-12-01)

Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
by: Anna Bonaterra-Pastra, et al.
Published: (2021-01-01)

Cerebral amyloid angiopathy mimicking central nervous system metastases: a case report
by: Christopher DeZorzi, et al.
Published: (2018-05-01)

Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry
by: Nobuto Kakuda, et al.
Published: (2017-10-01)

Exogenous Aβ seeds induce Aβ depositions in the blood vessels rather than the brain parenchyma, independently of Aβ strain-specific information
by: Tsuyoshi Hamaguchi, et al.
Published: (2021-09-01)

Normal pressure hydrocephalus and cerebral amyloid angiopathy: a set of diseases or the unity of pathogenesis?
by: E. G. Mendelevich
Published: (2020-12-01)

A Toxic Synergy between Aluminium and Amyloid Beta in Yeast
by: Jamieson B Mcdonald, et al.
Published: (2021-02-01)

Deep learning assisted quantitative assessment of histopathological markers of Alzheimer’s disease and cerebral amyloid angiopathy
by: Valentina Perosa, et al.
Published: (2021-08-01)

Infant critical head injury could be a remote cause of middle-aged cerebral amyloid angiopathy
by: Keisuke Tachiyama, et al.
Published: (2020-12-01)

Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy
by: Satoshi Saito, et al.
Published: (2021-02-01)

CD40L disruption enhances Aβ vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation
by: D. Obregon, et al.
Published: (2008-02-01)